Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1NET 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Sarcoma 47Osteosarcoma 15Dendritic Cell Sarcoma, Interdigitating 12Bone Neoplasms 11Rhabdomyosarcoma 9Gastrointestinal Stromal Tumors 8Sarcoma, Ewing 5Melanoma 5Sarcoma, Kaposi 4Recurrence 4Neurofibrosarcoma 4Neoplasms 4Liposarcoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Alveolar Soft Part 3Ovarian Neoplasms 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sarcoma, Synovial 2Pancreatic Neoplasms 2Neurofibromatosis 1 2Neuroblastoma 2Medulloblastoma 2Lung Neoplasms 2Leiomyosarcoma 2Leiomyoma 2Hodgkin Disease 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Fever × Sarcoma × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡